Ludwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells—a type of cancer ...

In a medical breakthrough, a 25-year-old woman from China achieved insulin independence through a pioneering stem cell procedure that could transform the treatment landscape for type 1 diabetes. This ...

The Denosumab for Type 1 Diabetes phase 1/2 clinical trial, is a collaborative study with the Arthur Riggs Diabetes and ...

According to Precedence Research, the global stem cell therapy market size was valued at USD 14.15 billion in 2023 and is expected to hit around USD 48.89 billion by 2033 with a CAGR of 13.2% from ...

Consistent high-quality products are crucial as key raw materials for safe and reliable cell manufacturing. We adhere to ...

Research provides evidence that a drug used to slow the progression of the disease ALS shows promise in suppressing the self-renewing cancerous stem cells that challenge the present standards of care ...

A groundbreaking discovery has recently brought hope to millions of people living with type 1 diabetes around the world. In a ...

There is a promising step forward to treat and possibly cure Type 1 diabetes, which is good news for Louisiana, as our state ...

Taiwan’s REGiMMUNE and Europe-based Kiji Therapeutics are merging to create a globally minded regulatory T-cell biotech that ...

Glioblastoma is the most common – and the most malignant – primary brain tumor in adults. It's aggressive and incurable.

Novo Nordisk scientists have synthesised an insulin molecule that specifically targets glucose in blood, instead of other sugars like fructose, to aid treatment of all types of diabetes.

Neuroscientists have uncovered a mechanism that controls the reactivation of neural stem cells, which are crucial for repairing and regenerating brain cells. The research offers exciting potential for ...